文献速递肺外科心外重症与机械循环支持

VA ECMO与off-pump肺移植的前瞻性随机试验中期分析

Venoarterial extracorporeal membrane oxygenation versus off-pump lung transplantation: Interim analysis of a prospective, randomized clinical trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-01-02

OBJECTIVE: Primary graft dysfunction (PGD) after lung transplantation (LTx) is associated with increased mortality. Retrospective studies have reported an inconsistent incidence of PGD when comparing intraoperative venoarterial extracorporeal membrane oxygenation (VA ECMO) with o…

要点

  • 中期分析未发现VA ECMO与off-pump肺移植在PGD 3级发生率上有显著差异。
  • VA ECMO组新鲜冰冻血浆和血小板输注量显著多于off-pump组。
  • 仍需继续入组以达到预计228例的样本量目标。

核心结论

  • 中期分析显示VA ECMO与off-pump肺移植在48-72小时PGD 3级发生率上无显著差异,需继续入组确保研究统计效能。

研究设计与样本

  • 前瞻性随机对照试验,比较术中VA ECMO与off-pump肺移植的90天结局,计划入组228例,目前6个中心在招募。
  • 纳入标准为年龄≥18岁、双肺移植且平均肺动脉压≤35 mmHg;排除多器官移植、循环死亡后捐献、再移植、计划术后ECMO、既往肺手术或胸膜固定术、术前ECMO或机械通气。
  • 患者按1:1随机分配至VA ECMO或off-pump组,采用意向性治疗分析,主要终点为48-72小时PGD 3级。

主要发现

  • 中期分析纳入75例患者,VA ECMO组44例(58.6%),off-pump组31例(41.3%)。
  • off-pump组有4例(12.9%)交叉到VA ECMO。
  • 安全性和15个次要终点均无显著差异,但VA ECMO组新鲜冰冻血浆和血小板输注显著更多。

临床怎么用

  • 对于符合入选标准的双肺移植患者,术中VA ECMO与off-pump策略在早期PGD风险上未见显著差异,但VA ECMO可能增加血制品输注。

局限性

  • 此为中期分析,样本量仅75例,未达到计划228例,统计效能不足,结论需最终分析确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Primary graft dysfunction (PGD) after lung transplantation (LTx) is associated with increased mortality. Retrospective studies have reported an inconsistent incidence of PGD when comparing intraoperative venoarterial extracorporeal membrane oxygenation (VA ECMO) with off-pump LTx. To address this, we initiated a prospective, randomized trial comparing intraoperative support techniques in LTx. METHODS: This trial compares intraoperative VA ECMO and off-pump LTx outcomes at 90 days. Six centers are currently enrolling. Inclusion criteria include age ≥18 years and bilateral LTx with mean pulmonary artery pressure ≤35 mm Hg. Exclusion criteria include multiorgan transplant, donation after circulatory death, retransplantation, planned postoperative ECMO, previous lung surgery or pleurodesis, and preoperative ECMO or mechanical ventilation. Patients were randomized 1:1 to VA ECMO or off-pump with an intention-to-treat analysis. The primary end point was PGD grade 3 at 48 to 72 hours, and 15 secondary end points were studied. Sample size estimation was determined to be 228 patients to detect a 15% absolute risk reduction in PGD grade 3 at 48 to 72 hours. RESULTS: The interim analysis includes 75 patients. Of these, 44 (58.6%) were randomized to VA ECMO and 31 (41.3%) to off-pump LTx. Four patients (12.9%) crossed over from off-pump to VA ECMO. There was no significant difference between groups in PGD grade 3 at 48 to 72 hours, VA ECMO 6 (13.6%) versus off-pump 6 (19.4%), P = .506. No significant differences were observed in the safety profile and secondary end points. There was significantly more fresh-frozen plasma and platelet transfusion in the VA ECMO group. CONCLUSIONS: In this interim analysis of the Veno-arterIal ECMO Versus Off-Pump Bilateral Orthotopic Lung Transplantation trial, no significant primary end-point difference was noted between VA ECMO and off-pump LTx. Continued enrollment is needed to ensure the study is adequately powered.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Villavicencio MA, Saddoughi SA, Spencer PJ, et al. Venoarterial extracorporeal membrane oxygenation versus off-pump lung transplantation: Interim analysis of a prospective, randomized clinical trial. J Thorac Cardiovasc Surg. 2026. PMID: 41485583. doi:10.1016/j.jtcvs.2025.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。